Wall Street Zen trims CVS Health to buy from strong-buy
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Wall Street Zen downgraded CVS Health (NYSE:CVS) from "strong-buy" to "buy," though the analyst consensus stays "Moderate Buy" with an average price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context